Insulin Lispro vs Glucagon
Head-to-head comparison of Insulin Lispro (Insulin lispro (B28-Lys, B29-Pro human insulin analog)) and Glucagon (Glucagon) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Insulin Lispro | Glucagon |
|---|---|---|
| Category | Diabetes & Metabolic | Diabetes & Metabolic |
| Full Name | Insulin lispro (B28-Lys, B29-Pro human insulin analog) | Glucagon |
| Molecular Weight | 5808.0 Da | 3482.75 |
| Half-Life | About 1 hour | 5-10 min |
| Amino Acids | 51 | 29 |
| Typical Dose | 0.05-0.2 U/kg per meal | 1 mg IM/SC for severe hypoglycemia or 3 mg intranasal |
| Route | Subcutaneous | IM|SC|IN|IV |
| Purity | ≥98% | ≥98% |
| Studies Count | 12000 | 93 |
| Research Status | Approved | Approved |
Insulin Lispro Benefits
- ✓Rapid postprandial glucose control
- ✓Flexible premeal timing
- ✓Predictable onset of action
- ✓Useful in basal-bolus regimens
Glucagon Benefits
- ✓rapid hypoglycemia reversal
- ✓raises plasma glucose
- ✓useful in emergency rescue
Insulin Lispro Dosing
Inject SC 0-15 minutes before meals|Adjust dose to carbohydrate intake and premeal glucose|Often paired with a basal insulin
Glucagon Dosing
1 mg IM/SC|3 mg intranasal
Insulin Lispro Side Effects
- ⚠Hypoglycemia
- ⚠Weight gain
- ⚠Injection-site reactions
Glucagon Side Effects
- ⚠nausea
- ⚠vomiting
Research Overview
Insulin Lispro
Clinical studies show faster onset and shorter duration than regular insulin, improving post-meal glucose control. It is a standard comparator in diabetes pharmacology and closed-loop insulin-delivery research.
Glucagon
Clinical and emergency medicine use is well established for severe hypoglycemia, with newer stable formulations improving ease of administration.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.